http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112516390-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M27-008 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-148 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-041 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-06 |
| filingDate | 2020-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112516390-B |
| titleOfInvention | A degradable ureteral stent |
| abstract | The invention provides a degradable ureteral stent, which is a round tubular structure, and the material used is a composite material formed by two elastomers with different degradation rates, and the material with a slower degradation rate is L-lactide/ε-hexane Lactone copolymer, the material with faster degradation rate is glycolide/ε-caprolactone copolymer. The degradable ureteral stent has the advantages of higher tensile strength, adjustable degradation time, more stable size after molding, excellent resilience, etc. It can not only take into account the degradation speed requirements of different clinical indications, but also achieve better mechanical properties. The composite material can also be blended with a medical imaging agent and a processing aid, and the ureteral stent of the present invention can be obtained by extrusion molding. |
| priorityDate | 2020-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.